Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
The Journal of Clinical Psychiatry
|
June 20, 2020
The Risk of Relapse of Depression During Pregnancy After Discontinuation of Antidepressants: A Systematic Review and Meta-Analysis
Hamideh Bayrampour, Arunima Kapoor, Mary Bunka, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 4, 2024
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al
Mary Bunka, Jehannine Austin, Louisa Edwards, et al.
Pharmacogenomics
|
October 14, 2025
Characterizing models for delivery of pharmacogenomic testing: a scoping review
Zeina Waheed, Mary Bunka, Louisa Edwards, et al.
Pharmacoeconomics
|
July 25, 2022
Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience
Mary Bunka, Shahzad Ghanbarian, Linda Riches, et al.
Psychiatry Research
|
February 13, 2023
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis
Mary Bunka, Gavin Wong, Dan Kim, et al.
Journal of Affective Disorders
|
May 7, 2026
Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation
Louisa Edwards, Colene Bentley, Kieran C O'Doherty, et al.
BMC Health Services Research
|
December 21, 2023
Costs of major depression covered / not covered in British Columbia, Canada
Sonya Cressman, Shahzad Ghanbarian, Louisa Edwards, et al.
BMJ Open
|
January 14, 2025
Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort
Rohit Vijh, Zeina Waheed, Sandra Peterson, et al.
Pharmacoeconomics - Open
|
March 26, 2024
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol
Shahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 14, 2023
Cost-effectiveness of pharmacogenomic-guided treatment for major depression
Shahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
The Journal of Clinical Psychiatry
|
June 20, 2020
The Risk of Relapse of Depression During Pregnancy After Discontinuation of Antidepressants: A Systematic Review and Meta-Analysis
Hamideh Bayrampour, Arunima Kapoor, Mary Bunka, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology
|
September 4, 2024
Regarding the meta-analyses of pharmacogenomics-guided antidepressant treatment: A response to Milosavljevic et al
Mary Bunka, Jehannine Austin, Louisa Edwards, et al.
Pharmacogenomics
|
October 14, 2025
Characterizing models for delivery of pharmacogenomic testing: a scoping review
Zeina Waheed, Mary Bunka, Louisa Edwards, et al.
Pharmacoeconomics
|
July 25, 2022
Collaborating with Patient Partners to Model Clinical Care Pathways in Major Depressive Disorder: The Benefits of Mixing Evidence and Lived Experience
Mary Bunka, Shahzad Ghanbarian, Linda Riches, et al.
Psychiatry Research
|
February 13, 2023
Evaluating treatment outcomes in pharmacogenomic-guided care for major depression: A rapid review and meta-analysis
Mary Bunka, Gavin Wong, Dan Kim, et al.
Journal of Affective Disorders
|
May 7, 2026
Pharmacogenomic testing for major depressive disorder in British Columbia, Canada: Recommendations from a public deliberation
Louisa Edwards, Colene Bentley, Kieran C O'Doherty, et al.
BMC Health Services Research
|
December 21, 2023
Costs of major depression covered / not covered in British Columbia, Canada
Sonya Cressman, Shahzad Ghanbarian, Louisa Edwards, et al.
BMJ Open
|
January 14, 2025
Relationship between pharmacotherapy for major depressive disorder and healthcare utilisation in British Columbia, Canada: a retrospective population-based cohort
Rohit Vijh, Zeina Waheed, Sandra Peterson, et al.
Pharmacoeconomics - Open
|
March 26, 2024
A Canadian Simulation Model for Major Depressive Disorder: Study Protocol
Shahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|
November 14, 2023
Cost-effectiveness of pharmacogenomic-guided treatment for major depression
Shahzad Ghanbarian, Gavin W K Wong, Mary Bunka, et al.
Page
of 1